Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $7.1650 (0.14%) ($7.1650 - $7.1650) on Fri. Oct. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.3% (three month average) | RSI | 40 | Latest Price | $7.1650(0.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.7% a day on average for past five trading days. | Weekly Trend | EDIT declines -5.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(73%) XBI(71%) IBB(62%) IBUY(61%) ARKK(60%) | Factors Impacting EDIT price | EDIT will decline at least -1.65% in a week (0% probabilities). TBT(-23%) UUP(-14%) VXX(-11%) VIXM(-9%) GLD(3%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.65% (StdDev 3.3%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-9.97(-239.15%) | Resistance Level | $7.71 | 5 Day Moving Average | $7.16(0.07%) | 10 Day Moving Average | $7.18(-0.21%) | 20 Day Moving Average | $7.71(-7.07%) | To recent high | -22.8% | To recent low | 3.5% | Market Cap | $445m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |